Gland Pharma Ltd. - Research Center
543245 GLAND Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 16.47 | 16.43 | 16.36 | 15.50 | 15.50 |
| Share application money | 1.67 | 0.08 | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 7,935.16 | 7,141.72 | 5,886.93 | 3,630.74 | 2,846.62 |
| Loan funds | |||||
| Secured loans | 3.82 | 3.93 | 3.93 | 4.07 | 4.96 |
| Unsecured loans | - | - | - | - | - |
| Total | 7,957.12 | 7,162.16 | 5,907.22 | 3,650.30 | 2,867.07 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 2,292.88 | 2,080.30 | 1,430.30 | 1,347.62 | 1,219.58 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 722.33 | 578.11 | 476.07 | 379.52 | 290.83 |
| Net block | 1,570.55 | 1,502.19 | 954.23 | 968.10 | 928.74 |
| Capital work-in-progress | 177.22 | 190.75 | 337.81 | 188.47 | 123.16 |
| Investments | 8.16 | 163.03 | 0.55 | - | - |
| Net current assets | |||||
| Current assets, loans & advances | 7,017.26 | 5,978.17 | 5,203.47 | 2,929.47 | 2,470.68 |
| Less : current liabilities & provisions | 816.06 | 671.98 | 588.84 | 435.74 | 655.51 |
| Total net current assets | 6,201.20 | 5,306.19 | 4,614.63 | 2,493.74 | 1,815.17 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 7,957.12 | 7,162.16 | 5,907.22 | 3,650.30 | 2,867.07 |
| Notes: | |||||
| Book value of unquoted investments | - | - | - | - | - |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 128.46 | 124.53 | 219.23 | 134.54 | 171.60 |
| Number of equity sharesoutstanding (Lacs) | 1647.01 | 1643.03 | 1635.93 | 1549.49 | 154.95 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis